Glutamate in the Pathogenesis of Gliomas
- 1 January 2022
- book chapter
- Published by Springer Nature
- p. 2029-2041
Abstract
No abstract availableKeywords
This publication has 54 references indexed in Scilit:
- Oncogene AEG-1 Promotes Glioma-Induced Neurodegeneration by Increasing Glutamate ExcitotoxicityCancer Research, 2011
- Increased concentrations of both NMDA receptor co-agonists d-serine and glycine in global ischemia: a potential novel treatment target for perinatal asphyxiaAmino Acids, 2011
- Selective induction of astrocytic gliosis generates deficits in neuronal inhibitionNature Neuroscience, 2010
- Phase 2 trial of talampanel, a glutamate receptor inhibitor, for adults with recurrent malignant gliomasCancer, 2010
- Genetic alterations and signaling pathways in the evolution of gliomasCancer Science, 2009
- A multigene predictor of outcome in glioblastomaNeuro-Oncology, 2009
- Glioblastoma Cells Require Glutamate Dehydrogenase to Survive Impairments of Glucose Metabolism or Akt SignalingCancer Research, 2009
- The Multifaceted Role of MTDH/AEG-1 in Cancer ProgressionClinical Cancer Research, 2009
- Talampanel With Standard Radiation and Temozolomide in Patients With Newly Diagnosed Glioblastoma: A Multicenter Phase II TrialJournal of Clinical Oncology, 2009
- Autocrine Glutamate Signaling Promotes Glioma Cell InvasionCancer Research, 2007